Tests in

Dementia Panel

  • Test Code:
  • Department:
    Molecular Genetics
  • Test Synonyms:
    Alzheimer • Early onset Alzheimer • ALS2 • ANG • APOE • APP • C9ORF72 • CHMP2B • CSF1R • DCTN1 • FIG4 • FUS • GRN • MAPT • OPTN • PRNP • PSEN1 • PSEN2 • SETX • SORL1 • TARDBP • TREM2 • VCP
View Test

Diffuse Large B-Cell Lymphoma (DLBCL) FISH Panel

  • Test Code:
    7450
  • Department:
    Cancer FISH
  • Test Synonyms:
    DLBCL FISH • DLBL FISH • B-Cell Lymphoma
View Test

DiGeorge Syndrome (TUPLE1) FISH

  • Test Code:
    7140
  • Department:
    Constitutional FISH
  • Test Synonyms:
    Velocardiofacial syndrome • VCFS • DGS • Deletion 22q11.2 syndrome
View Test

Dilated Cardiomyopathy Panel

  • Test Code:
  • Department:
    Molecular Genetics
  • Test Synonyms:
    ABCC9 • ACTC1 • ACTN2 • ANKRD1 • BAG3 • CRYAB • CSRP3 • DES • DMD • DSG2 • DSP • EMD • EYA4 • FKTN • GATAD1 • ILK • LAMA4 • LAMP2 • LDB3 • LMNA • MYBPC3 • MYH6 • MYH7 • MYPN • NEBL • NEXN • PDLIM3 • PKP2 • PLN • RAF1 • RBM20 • SCN5A • SGCD • TAZ • TCAP • TMPO • TNNC1 • TNNI3 • TNNT2 • TPM1 • TTN • TXNRD2 • VCL
View Test

Disorders of Sex Development Panel

  • Test Code:
    1697
  • Department:
    Molecular Genetics
  • Test Synonyms:
    Ambiguous genitalia • Bifid scrotum • Cryptorchidism • DSD • Gonadal dysgenesis • Hypogonadotropic hypogonadism • Hypospadius • Micropenis • Sex reversal
View Test

Duchenne/Becker Muscular Dystrophy, DMD/BMD, Deletion/Duplication

  • Test Code:
    1280
  • Department:
    Molecular Genetics
  • Test Synonyms:
    Becker Muscular Dystrophy • Duchenne Muscular Dystrophy • DMD • BMD • Dystrophin
View Test

Dyslipidemia Panel

View Test

Dystonia Panel

  • Test Code:
  • Department:
    Molecular Genetics
  • Test Synonyms:
    Dystonic features • ADAR • AFG3L2 • AP1S2 • APTX • ARSA • ARX • ATM • ATP13A2 • ATP1A2 • ATP1A3 • ATP7B • AUH • C19orf12 • CACNA1A • CHMP2B • CP • CYP27A1 • DCAF17 • DDC • DLAT • DRD2 • DRD5 • EARS2 • ERCC6 • FA2H • FASTKD2 • FBXO7 • FOXG1 • FOXRED1 • GAMT • GCDH • GCH1 • HPRT1 • KCNQ2 • L2HGDH • MAT1A • MCOLN1 • MMADHC • MPV17 • MR1 • NPC2 • PANK2 • PARK2 • PDHX • PINK1 • PLA2G6 • PLP1 • PNKD • PRRT2 • PSEN1 • PTEN • PTS • QDPR • RNASEH2A • RNASEH2B • RNASEH2C • SAMHD1 • SCP2 • SDHAF1 • SGCE • SLC19A3 • SLC20A2 • SLC2A1 • SLC46A1 • SLC6A3 • SPR • SUCLA2 • SUOX • TAF1 • TH • THAP1 • TIMM8A • TOR1A • TPK1 • TREM2 • TREX1 • VPS13A • WDR45
View Test
Innovations in Testing
View All Tests

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More